Aviv Scientific

Aviv Scientific specializes in the treatment of age-related cognitive and functional decline, with a focus on novel applications of hyperbaric medicine to maximize human performance. The company aims to improve the aging process by increasing cognitive and physical performance in healthy aging adults. Based on an exclusive global partnership with the worlds largest hyperbaric medicine and research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is rolling out a global network of medical clinics focused on the enhancement of cognitive and physical performance with hyperbaric medicine and related technologies at its core. The Aviv Medical Program combines the unique protocols of hyperbaric oxygen therapy (HBOT) with a proprietary personalized program of cognitive and physical training. More than 1,000 people worldwide have already been treated in accordance with Avivs progressive 12-week program, currently offered at Aviv clinics in Florida and Dubai. Aviv Scientific has successfully combined personalized medicine, advanced technologies, big data, and analytics with its specialized operational skills to build a worldwide network of medical clinics.

Aviv Scientific has raised $62M in total funding across 2 rounds. The company is currently at the B stage. Key investors include Deep Insight, Danel Group.

Aviv Scientific was founded in 2017 by Shai Efrati (Co-founder & Chairman of the Medical Advisory Board), Jonathan Preminger (Co-founder & CEO), Michael Lobel (Co-founder & Chief Business Officer).

Aviv Scientific operates in Health Tech & Life Sciences, Digital Healthcare, Digital Therapeutics, with core technologies in Artificial Intelligence, Platforms & Interfaces, Mobile, Semiconductors & Electronics, Wearables. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Consumers, Demographics & Family, Seniors.

Aviv Scientific is based in Metsada St 7, Bnei Brak, Israel, Center District. The company also has offices abroad.